发明名称 |
Biologically active tgf-beta 1 and tgf-beta 2 peptides |
摘要 |
The invention relates to peptides corresponding to regions of the amino acid sequence of TGF- beta 1 or TGF- beta 2 which retain, either in monomeric or polymeric forms, at least some of the biological activity of the respective full length TGF- beta . The monomeric form of the peptide derived from TGF- beta 1 comprises the following amino acid sequence: CVRQLYIDFRKDLGWKWIHEPKGYHANFCLGP (SEQ ID NO: 1). The monomeric form of the peptide derived from TGF- beta 2 comprises the following amino acid sequence: CLRPLYIDFKRDLGWKWIHEPKGYNANFCAGA (SEQ ID NO: 2). Dimers may be formed via disulfide bonds between the amino-terminal cysteine residues, the carboxy-terminal cysteine residues, or amino- and carboxy-terminal cysteine residues of the monomer subunits. |
申请公布号 |
AU6093294(A) |
申请公布日期 |
1994.08.15 |
申请号 |
AU19940060932 |
申请日期 |
1994.01.21 |
申请人 |
CELTRIX PHARMACEUTICALS, INC. |
发明人 |
YASUSHI OGAWA;DAVID SCHMIDT |
分类号 |
A61K38/22;A61K38/00;A61P19/00;A61P29/00;A61P43/00;C07K14/495 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|